Home › NDC Lookup › Ingredients › Caffeine › 46122-0457-73
Alert Aid Caffeine 200 mg Tablet, 16-count — NDC 46122-0457-73 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Alert Aid Caffeine 200 mg Tablet, 16-count — NDC 46122-457-73 (Billing 46122-0457-73)

by Amerisource Bergen · 2 BLISTER PACK in 1 CARTON / 8 TABLET in 1 BLISTER PACK

This is a package of 16 tablets of Alert Aid Caffeine 200 mg Tablet from Amerisource Bergen, marketed since Nov 1996 and currently FDA-listed; retail pharmacies pay about $0.0830 per tablet (NADAC). It is this product's only package size.

NDC 46122-0457-73
🏷️ FDA NDC (as labeled) 46122-457-73 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 46122-457-73 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
46122 labeler · 457 product · 73 package
Package marketed since
Nov 21, 1996
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
16 EA per package
Barcode (UPC)
0346122457736
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 46122-457-73
Product NDC 46122-457
11-digit billing NDC 46122045773
NCPDP billing unit EA — each (per item)
RxCUI 198520
UNII 3G6A5W338E
UPC 0346122457736
Application # M011
SPL Set ID 7f80346e-fe30-4a22-aa42-193c5fad93a2
Established class (EPC) Central Nervous System Stimulant; Methylxanthine
Physiologic effect Central Nervous System Stimulation
Chemical class Xanthines
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1996-11-21
Route ORAL
Dosage form TABLET
Substance CAFFEINE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 61300010000320
GPI class GNP Alert Aid
GCN Seq No 000033
GCN 00212
HICL code 000012
Ingredient (HICL) Caffeine
HIC1 code A
Therapeutic class — broad (HIC1) Cardiovascular System
HIC2 code A1
Therapeutic class — intermediate (HIC2) Cardiac Stimulants
HIC3 code A1B
Therapeutic class — specific (HIC3) Xanthines
AHFS code 28:20.32.00
AHFS class Respiratory And Cns Stimulants
FDB label name ALERT AID 200 MG TABLET
FDB brand name Alert Aid
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 000033
  • GCN: 00212
  • GPI-14 (Medi-Span): 61300010000320
  • HICL (First Databank): 000012
  • AHFS class code: 28:20.32.00
  • RxCUI (RxNorm): 198520
Why two NDCs? The FDA registers this code as 46122-457-73 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 46122-0457-73. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Central Nervous System Stimulant class.

Pharmacologic class Central Nervous System Stimulant, Methylxanthine
Drug family (ATC) Tests for gastric secretion, Other dermatologicals, Xanthine derivatives
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name ALERT AID 200 MG TABLET Ingredient Caffeine
📗 Our plain-language guide HelloPharmacist
  • It is used short term to treat apnea of prematurity, which means pauses in breathing in premature infants. It is given as an injection or an oral solution by the healthcare team.
  • The baby usually gets a one-time loading dose into a vein, then a smaller maintenance dose about every 24 hours. The maintenance dose can be given into a vein or by mouth. The dose...
  • Babies may be jittery or irritable, have a fast heart rate, have feeding problems, or have a rash. Blood sugar and urine output can also change. Tell the care team if you notice an...
  • Yes. Necrotizing enterocolitis, a serious intestinal problem in premature infants, was seen in trials. A cause was not proven, and the team watches closely for it. Too much caffein...
📖 Read our full Caffeine guide →
1
Nutrient depletion considerations

Caffeine (OTC drug) may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Caffeine (OTC drug) nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.083 $1.33 / 16 tablets
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Nov 2021 Aug 2022 Jan 2026 Sep 2026 $0.089 $0.063
▲ Up 23% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
46122-0457-73 You're viewing this Main listing 2 BLISTER PACK in 1 CARTON / 8 TABLET in 1 BLISTER PACK 1996-11-21 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Alert Aid 200 mgthis 46122-0457-73 Amerisource 16 tablets $0.083 — Availability likely —
Caffeine 200 mg 70000-0409-01 LEADER/ 16 tablets $0.083 — Availability likely —
Stay Awake 200 mg 70677-1126-01 Strategic 16 tablets $0.083 — Availability likely —
Stay Awake 200 mg 83324-0074-16 Chain 16 tablets $0.083 — Availability likely —
Awake Maximum Strength 200 mg 00363-3440-11 Walgreen 60 tablets — — FDA listed —
Caffeine 200 mg 00363-5009-01 Walgreen 100 tablets — — FDA listed —
stay awake 200 mg 11822-2260-02 Rite 100 tablets — — FDA listed —
JET ALERT Double Strength 200 mg 15579-0200-16 Bell 90 tablets — — FDA listed —
Stay Awake Maximum Strength 200 mg 21130-0226-10 Better 40 tablets — — FDA listed —
Awake Maximum Strength 200 mg 21130-0944-11 Better 60 tablets — — FDA listed —
Stay Awake 200 mg 30142-0284-40 KROGER 40 tablets — — FDA listed —
Stay Awake 200 mg 30142-0726-10 Kroger 40 tablets — — FDA listed —
Awake Maximum Strength 200 mg 36800-0844-11 Topco 60 tablets — — FDA listed —
Stay Awake 200 mg 41163-0226-10 United 40 tablets — — FDA listed —
Stay Awake Maximum Strength 200 mg 41163-0434-11 United 60 tablets — — FDA listed —
Stay Awake 200 mg 49035-0226-31 Wal-Mart 80 tablets — — FDA listed —
Alert 200 mg 49483-0343-44 Time 40 tablets — — FDA listed —
Stay Awake 200 mg 50804-0262-10 Geiss, 40 tablets — — FDA listed —
Alert Alertness Aid 200 mg 50844-0226-12 L.N.K. 100 tablets — — FDA listed —
Stay Awake 200 mg 53943-0320-02 DISCOUNT 40 tablets — — FDA listed —
Stay Awake 200 mg 55301-0226-10 ARMY 40 tablets — — FDA listed —
Alert 200 mg 55910-0226-21 DOLGENCORP, 16 tablets — — FDA listed —
stay awake 200 mg 56062-0030-01 PUBLIX 16 tablets — — FDA listed —
Stay Awake 200 mg 57243-0226-21 Salado 16 tablets — — FDA listed —
Stay Awake 200 mg 57344-0220-02 AAA 40 tablets — — FDA listed —
caffeine 200 mg 58602-0747-47 Aurohealth 40 tablets — — FDA listed —
Stay Awake 200 mg 63868-0114-16 CHAIN 16 tablets — — FDA listed —
Stay Awake 200 mg 63941-0020-01 VALU 16 tablets — — FDA listed —
NoDoz Alertness Aid 200 mg 66715-9899-03 Lil' 2 tablets — — FDA listed —
Stay Awake 200 mg 67091-0117-16 WinCo 16 tablets — — FDA listed —
Vivarin 200 mg 67751-0226-04 Navajo 4 tablets — — FDA listed —
Alertness Aid 200 mg 68016-0680-16 Chain 16 tablets — — Discontinued —
Stay Awake 200 mg 68998-0076-84 Marc 8 tablets — — FDA listed —
Stay Awake 200 mg 69168-0076-40 Allegiant 40 tablets — — FDA listed —
Caffeine 200 mg 69842-0500-11 CVS 60 tablets — — FDA listed —
Caffeine 200 mg 69842-0509-10 CVS 40 tablets — — FDA listed —
Vivarin 200 mg 71179-0018-16 Vespyr 16 tablets — — FDA listed —
Stay Awake 200 mg 72036-0020-02 Harris 40 tablets — — FDA listed —
Stay Awake 200 mg 72476-0102-01 RETAIL 16 tablets — — FDA listed —
Topcare Stay Awake Maximum Strength 200 mg 76162-0002-58 TopCo 8 tablets — — FDA listed —
Stay Awake 200 mg 83059-0008-01 Shield 15 tablets — — Discontinued —
Stay Awake 200 mg 83059-0097-03 Shield 30 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1996
On the market since
Nov 1996
📍
2026
Currently FDA-listed
30 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color yellow
ShapeRound
Imprint44;226
Size11 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII CQ3XH3DET6
    D&C Yellow No. 10 Aluminum Lake is a yellow colorant made by combining a dye with aluminum salts. It's used in medicines to add color for product identification and visual appeal.
  • UNII LX22YL083G
    A simple sugar derived from corn or other sources. It acts as a filler to give the medicine bulk and volume, and as a sweetener to improve taste in oral medications.
  • UNII O7TSZ97GEP
    A mineral compound that serves as a filler and binding agent in tablets and capsules. It adds bulk to the medicine and helps hold ingredients together during manufacturing.
  • UNII GYP6Z2JR6Q
    FD&C Yellow No. 6 Aluminum Lake is a yellow colorant made by combining FD&C Yellow No. 6 dye with aluminum salts. It's used to color tablets, capsules, and other medicines so they're easier to identify.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII O8232NY3SJ
    A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.

8 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statescorn starch, D&C yellow #10 aluminum lake, dextrates hydrated, dibasic calcium phosphate dihydrate, FD&C yellow #6 aluminum lake, magnesium stearate, microcrystalline cellulose, silicon dioxide

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAmerisource Bergen
FDA applicationM011 (OTC MONOGRAPH DRUG)
Labeler code46122
First marketedNov 1996
Product typeHuman Otc Drug
Portfolio206 products on file

More NDCs from Amerisource Bergen labeler code 46122

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 12 words ▾

Use helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness

⏱️ Dosage and Administration 27 words ▾

Directions adults and children 12 years and over: take 1 tablet not more often than every 3 to 4 hours children under 12 years: do not use

⚠️ Warnings 111 words ▾

Warnings For occasional use only Caffeine warning: The recommended dose of this product contains about as much caffeine as a cup of coffee. Limit the use of caffeine-containing medications, foods, or beverages while taking this product because too much caffeine may cause nervousness, irritability, sleeplessness, and, occasionally, rapid heart beat. Do not use for children under 12 years of age as a substitute for sleep Stop use and ask a doctor if fatigue or drowsiness persists or continues to recur.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 42 words ▾

Other information each tablet contains: calcium 35 mg TAMPER EVIDENT: DO NOT USE IF OUTER PACKAGE IS OPENED OR BLISTER IS TORN OR BROKEN store at 25°C (77°F); excursions permitted between 15°-30°C (59°-86°F) see end flap for expiration date and lot number

🧪 Active Ingredient 8 words ▾

Active ingredient (in each tablet) Caffeine 200 mg

🧪 Inactive Ingredients 26 words ▾

Inactive ingredients corn starch, D&C yellow #10 aluminum lake, dextrates hydrated, dibasic calcium phosphate dihydrate, FD&C yellow #6 aluminum lake, magnesium stearate, microcrystalline cellulose, silicon dioxide

🎯 Purpose 3 words ▾

Purpose Alertness aid

📄 Do Not Use 15 words ▾

Do not use for children under 12 years of age as a substitute for sleep

📄 Stop Use and Ask a Doctor If 15 words ▾

Stop use and ask a doctor if fatigue or drowsiness persists or continues to recur.

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 4 words ▾

Questions or comments? 1-800-426-9391

📄 Package Label / Principal Display Panel 107 words ▾

Principal display panel Good Neighbor Pharmacy® Compare to Vivarin® active ingredient* NDC 46122-457-73 Alert Aid caffeine 200 mg Alertness Aid Equal to about a cup of coffee 16 Tablets | 200 mg Each Actual Size • Helps restore mental alertness • Equal to about a cup of coffee TAMPER EVIDENT: DO NOT USE IF PACKAGE IS OPENED OR IF BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING *This product is not manufactured or distributed by Vespyr Brands, Inc., owner of the registered trademark Vivarin®. 50844 REV1219D22621 Distributed By AmerisourceBergen 1 West First Avenue, Conshohocken, PA 19428 Questions or Concerns? www.mygnp.com GNP 44-226 GNP 44-226

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Alert Aid (this brand).

Top reported reactions

Toxicity To Various Agents1,367
Fatigue1,274
Pain1,147
Arthralgia1,079
Alopecia1,077
Vomiting1,061
Dyspnoea1,054

Reporter sex

7,481 reports

Serious outcomes

Death3,097
Life-threatening1,956
Disabling1,764
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 907 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 46122-0455-52 · Amerisource 46122-0461-19 · AmerisourceBergen →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.